Literature DB >> 26781153

Percutaneous CT guided lung biopsy in patients with pulmonary hypertension: Assessment of complications.

Subba R Digumarthy1, Bojan Kovacina2, Alexi Otrakji3, Michael Lanuti4, Jo-Anne O Shepard3, Amita Sharma3.   

Abstract

PURPOSE: To assess the complications of CT-guided percutaneous transthoracic needle aspiration and/or core biopsy (PTNAB) of lung nodules in patients with pulmonary arterial hypertension (PHTN). METHOD AND MATERIALS: We analyzed PTNAB of 74 lung lesions (mean size: 3.6 ± 2.1 cm) in 74 patients (M: F 38:36; age 68 ± 15 years) with documented PHTN on cardiac ultrasound. 39 patients with lung lesions (M: F 24:15; age 65 ± 14) who underwent PTNAB in the same period with right ventricle systolic pressure (RVSP) <35 mm Hg were selected as controls. Pulmonary arterial pressures were estimated on cardiac ultrasounds by using the tricuspid regurgitation jet method. Two thoracic radiologists reviewed the medical records and PTNAB images on a PACS station and documented nodule size, location, distance traversed in lung, technical success and complications.
RESULTS: Fine needle aspirates were obtained in all and core biopsy in 23% (17/74) of the nodules. 61% (45/74) of the nodules were in the middle and 39% (29/74) were in the outer third of lung. PHTN was mild, moderate and severe in 84% (62/74), 13% (10/74) and 3% (2/74) of the patients. Biopsy was complicated by hemorrhage in 26% (19/74), moderate hemoptysis in 1.3% (1/74), pneumothorax in 17% (12/74), chest tube in 1.3% (1/74) and hemothorax in 1.3% (1/74) of the patients. The complications rate in control group was similar, hemorrhage in 33% (19/39) (p=0.6), moderate hemoptysis in 5% (2/39) (p=0.3), pneumothorax in 28% (11/39) (p=0.2), chest tube in (0/39) (p=0.3), and hemothorax in 3% (1/39) of the patients (p=0.7).
CONCLUSION: Percutaneous needle biopsy of lung lesions in patients with mild to moderate PHTN can be performed without significant increase in complications.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Biopsy; CT; Chest; Lung nodules; Pulmonary hypertension

Mesh:

Year:  2015        PMID: 26781153     DOI: 10.1016/j.ejrad.2015.12.007

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  6 in total

1.  Hemoptysis associated with percutaneous transthoracic needle biopsy: Development of critical events checklist and procedure outcomes.

Authors:  Piera C Robson; David O'Connor; Perri Pardini; Terrah F Akard; Mary S Dietrich; Alan Kotin; Alexandra Solomon; Mohit Chawla; Matthew Kennedy; Stephen B Solomon
Journal:  J Radiol Nurs       Date:  2021-05-25

2.  Risk factors for haemoptysis after percutaneous transthoracic needle biopsies in 4,172 cases: Focusing on the effects of enlarged main pulmonary artery diameter.

Authors:  Eui Jin Hwang; Chang Min Park; Soon Ho Yoon; Hyun-Ju Lim; Jin Mo Goo
Journal:  Eur Radiol       Date:  2017-10-23       Impact factor: 5.315

3.  Logistic regression analysis and a risk prediction model of pneumothorax after CT-guided needle biopsy.

Authors:  Yanfeng Zhao; Xiaoyi Wang; Yong Wang; Zheng Zhu
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

4.  Determining malignancy in CT guided fine needle aspirate biopsy of subsolid lung nodules: Is core biopsy necessary?

Authors:  Nantaka Kiranantawat; Shaunagh McDermott; Milena Petranovic; Mari Mino-Kenudson; Ashok Muniappan; Amita Sharma; Jo-Anne O Shepard; Subba R Digumarthy
Journal:  Eur J Radiol Open       Date:  2019-05-04

5.  Risk factors associated with pulmonary hemorrhage and hemoptysis following percutaneous CT-guided transthoracic lung core needle biopsy: a retrospective study of 1,090 cases.

Authors:  Jianbin Zhu; Yaoming Qu; Xianlong Wang; Chunxiu Jiang; Jianhua Mo; Jiandong Xi; Zhibo Wen
Journal:  Quant Imaging Med Surg       Date:  2020-05

6.  A prospective study on the diagnosis of peripheral lung cancer using endobronchial ultrasonography with a guide sheath and computed tomography-guided transthoracic needle aspiration.

Authors:  Jun Zhu; Feng Tang; Ye Gu
Journal:  Ther Adv Med Oncol       Date:  2018-01-22       Impact factor: 8.168

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.